Object. Nonmalignant pain has been treated in the past century with ablative, or more appropriately, destructive procedures. Although individual outcomes for these procedures have previously been described in the literature, to the authors' knowledge this is the first comprehensive and systematic review on this topic.
F rom the early 20th century onward, the treatment of pain has constituted a central component of neu rosurgery. Various operations have been used over the years and, as the anatomical and physiological knowledge of pain pathways has grown, new destructive techniques have been developed to target different components of the ascending pain pathways. 15, 59 Techniques targeting different locations along the afferent pain pathway have been used for an array of pain conditions. 60, 61, 104, 105 In addition to the anterolateral quadrant of the spinal cord, other targets of destructive surgery have included the following: the sensory and sympathetic ganglia; the dorsal and ventral spinal roots; the DREZ; and the decussating extralemniscal fibers. Despite their long history and purported efficacy, the use of destructive techniques has generally declined in modern practice, although there are a few notable exceptions. 60 Destructive techniques are being replaced with newer pharmaceutical agents and nondestructive treatments, such as spinal cord stimulators and intrathecal opiate pumps. However, these techniques are not without disadvantages. For example, chronic administration of opioids can lead to high tolerance, high costs, and has an abuse potential that can place both the patient and prescribing physician at odds with societal norms. 5, 32 These risks have the potential to leave the patient undertreated and the physician under regulatory agency scrutiny. Moreover, neurostimulation and intrathecal drug administration can be expensive and require ongoing battery and catheter maintenance as well as pump refills. 144 Furthermore, the clinical efficacy of these techniques has not been proven according to modern standards of evidence-based medicine, as demonstrated in an excellent review by Coffey and Lozano. 21 The foregoing considerations prompted us to review published data on destructive procedures for nonmalignant pain. Our goal was to determine the degree of evidence supporting continued use and to help define areas that warrant further study. Therefore we reviewed human clinical studies that reported outcomes for destructive techniques used in the treatment of nonmalignant pain conditions. Reviewed studies were grouped according to the surgical target, beginning with peripheral or "firstorder neuron" targets. 59 
Methods
Using the US National Library of Medicine PubMed database, we located articles with the following search terms: "ablation-," "DREZ-," "dorsal root entry zone-," "cingulotomy-," "cordotomy-," "ganglionectomy-," "mes en cephalotomy-," "myelotomy-," "neurotomy-," "neurectomy-," "rhizotomy-," "sympathectomy-," "thalamotomy-," "tractotomy-," and "pain-." Using this strategy, we examined and reviewed evidence related to the procedures themselves, rather than a disease-or syndrome-specific review.
Our review focused on articles published between January 1966 and August 2006, inclusive. Earlier literature was located through review of references cited in other works, including book chapters and reviews. Limits placed on the search included "language = English" and "human." Any peer-reviewed articles that described clinical outcomes or efficacy for the treatment of nonmalignant pain, such as clinical trials, case series, meta-analyses, and RCTs, were included. Review articles were only used to extract any additional articles not found within the initial search and were not included as separate articles. In general, single case studies were excluded. Articles were also obtained through review of the identified publications' bibliographies. Attempts were made to eliminate redundant descriptions of the same patient series. Only studies pertaining to nonmalignant sources of pain were considered; many articles, however, included combined data for both malignant and nonmalignant pain. In these cases, care was taken to extract only information relevant to nonmalignant pain.
Results
In total, 146 articles were reviewed based on the criteria described here. Each procedure investigated in this article tended to have a distinct epoch during which numerous case series relevant to that procedure were published (Fig. 1) . The large majority of studies (131) constituted Class III evidence. Eleven Class I and 4 Class II studies were found. In 13 of these studies radiofrequency rhizotomies were evaluated for different pain origins such as LFS, cervical facet pain, and Type I (typical) TN, whereas in the other 2, ganglionectomies for either lumbar or cervical pain were examined. In no case were Class I or II studies directed at neuropathic pain states.
Rhizotomy Studies
In our database search and secondary review of references we located 47 rhizotomy studies that generally concerned spinal or facet pain and facial pain syndromes (Table 1 ). In the majority of the studies (34 of 47) the data reported were relevant to either TN ( ), whereas in the remainder the effects of rhizotomy on a variety of truncal and extremity neuralgias (Table 1, third section; 1 study  87 ), cervical pain (Table  1, fourth section; 9 studies   7,45,75,78,113,132,147,148,151 ) or cluster headaches (Table 1, fifth section; 3 studies   19,93,134 ) were evaluated.
Truncal or Extremity Neuralgias and LFS.
The earliest publications to describe the effects of dorsal root rhizotomies on a variety of localized pain syndromes (5 case series) were published between 1966 and 1973. 30, 74, 88, 117, 153 In 2 reports on 62 patients, a success rate (variably defined) of just over 60% was found in each. In 3 other series of 12-286 patients, a similar initial success rate was reported, but much lower long-term results (25-50%) were found. Despite the variability in treated pain syndromes, number of sectioned roots, outcome measures, and follow-up, the results were apparently discouraging enough that the procedure was relatively abandoned and replaced with modified rhizotomies directed at facet denervation for the treatment of LFS. 74 Radiofrequency rhizotomies of the medial branch of the dorsal root were compared to sham (3 studies) or intrafacetal versus extrafacetal rhizotomies (1 study) in 5 blinded RCTs. Outcome measures and patient selection differed sufficiently between the groups to preclude a meta-analysis. 51 In all 3 papers in which treatment versus sham was evaluated, however, modest long-term improvement in pain scores in the treated group was reported. In the last study, intrafacetal rhizotomies were superior to extrafacetal procedures. Complications were minimal in all 5 studies. Four of the remaining 14 papers were prospective in nature. Patients with "good outcomes" varied from 41 to 75% in long-term follow-up. The remaining 7 series are classified as Class III studies, and the reported long-term success rates were 40-60% (see Table 1 , second section; 14 studies).
Chronic Discogenic Back Pain. In 1 RCT 87 (Table 1 , third section), the effects of radiofrequency lesions of the ramus communicans for treatment of single-level chronic discogenic back pain were evaluated. Selected patients in whom an intradiscal electrothermal procedure had previously failed had a good response to local nerve blockade of the ramus communicans. Patients with other identifiable causes of back pain such as LFS, radiculopathy, and so on were excluded. At 1 and 4 months of follow-up, the treated group showed significant improvement on the VAS and medical outcomes study 36-Item Short Form Health Survey (SF-36).
Cervical Pain. Three RCTs 75, 132, 147 were reviewed in which radiofrequency rhizotomies were compared with sham procedures for the treatment of cervical pain 75, 147 or cervicogenic headache. 132 One prospective Class II clinical trial 45 and 4 case series were also reviewed. The number of patients in each RCT was small and ranged from 12 to 24. 75 Patients enrolled in each study were carefully selected based on their response to repeated nerve blocks with local anesthetics and followed for from 8 weeks to 3 years. Two of the RCTs demonstrated a significant treat-ment effect of radiofrequency lesions, 75, 147 although the other one did not. 132 The Class II study 45 also reported a durable reduction in validated pain scores. One study failed to demonstrate any effect and was underpowered. 132 Both studies 45, 75 with long-term follow-up demonstrated similar median times to recurrence (Table 1 , fourth section; 9 studies).
Rhizotomy for TN.
No controlled trials were located in which the treatment of TN by rhizotomy was reviewed. The best evidence consisted of 2 Class II and 3 Class III studies that prospectively followed patients with TN who were treated with radiofrequency rhizotomy or glycerol rhizolysis, as well as a large (1600 patients) case series. 63 Pain recurrence rates were evaluated with life-table analyses in 3 studies, 17, 63, 133 and in 2 of these studies separate cohorts of patients defined by symptomatology 163 or treatment protocol were prospectively compared. 95 Overall, these studies demonstrate a significant longterm benefit from rhizotomy for TN. Reported recurrence rates concurred, 40-60% at 5 years. Further studies are required to identify those patients most at risk for recurrence. Several authors have suggested that patients with facial pain other than typical or Type I TN 16 had higher recurrence rates or poorer satisfaction 17, 92, 163 (see Table 1 , first section; 20 studies).
Neurectomy for TN. Four additional case series pertaining to the treatment of TN 90, 102, 142, 165 were found with the search word "neurectomy" and are summarized in the first section of 
Sympathectomy Studies
A Cochrane review on sympathectomy was located using the search criteria indicated earlier. 77 The review criteria they used included all randomized clinical trials, controlled clinical trials, observational studies (cohorts and case-control studies), and relevant retrospective reviews of patient charts. Uncontrolled trials such as case series, case reports, and uncontrolled before and after studies were excluded. The Cochrane review did not place any language restriction on their review. They included patients of all ages who had nonmalignant neuropathic pain of any duration affecting the face, upper extremity, and lower extremity. They included only surgical (cervicothoracic or lumbar sympathetic chain ablation or coagulation by open, endoscopic, laser, or radiofrequency) or chemical (phenol or alcohol solution injected into cervicothoracic or lumbar sympathetic chain) sympathectomy.
A total of 223 titles and abstracts was produced from their search. Their systematic review showed that treating neuropathic pain by sympathectomy is based on very limited evidence. Our database search failed to demonstrate any additional studies.
Ganglionectomy Studies
A total of 17 articles was found that met the selection criteria indicated above. Two of these studies were RCTs: in one 44 radiofrequency lumbar ganglionectomy was compared to sham surgery for sciatica and in the other radiofrequency lesions made at 2 different temperatures were compared. 125 The remaining articles were case series ranging in size from 3 to 102 patients ( Table 2 , 17 studies 29, 34, 44, 52, 56, 64, 76, 80, 85, 89, 112, 125, 126, 131, 138, 152, 154 ).
Lumbar and Cervical Radicular Pain. Geurts et al. 44 in 2003 randomized 83 patients to receive either radiofrequency lesioning (45 patients) or needle placement without radiofrequency lesioning (38 patients) of a selected lumbar ganglion. Inclusion criteria limited the study to adult patients with clear radicular pain symptoms. Patients were further selected by their response to repeated local nerve blocks. Patients were only enrolled and randomized if their pain was limited to a single root and they experienced pain relief with application of local anesthetic to that root alone in repeat trials. Evaluators and patients were blinded to the protocol used. Despite adequate power, no statistical difference was found between groups.
Slappendel et al 125 in 1997 found no difference in outcomes between patients receiving a radiofrequency lesion at 67°C (Group I) and one at 40°C (Group II) for cervicobrachialgia. A reduction in VAS score of > 2 was found in 47 and 51% of patients in Groups I and II, respectively.
In a case series of 61 patients with sciatica, 138 59% had "markedly reduced" postoperative pain at follow-up durations ranging between 1 month and 15 years. Definite conclusions regarding long-term outcomes are difficult given the variability in follow-up data. The remaining studies were small and inconsistent.
Occipital Neuralgia. The largest case series 56 evaluated the efficacy of C-2 ganglionectomies for occipital neuralgia. These authors found that 80% of patients had significant relief from symptoms. Unfortunately, longterm follow-up data were unclear, rendering any conclusions difficult. The second largest series of patients with occipital neuralgia 76 compared ganglionectomies performed in patients with occipital pain described as either "sharp, burning, jabbing, electrical, or exploding" (Group I) or "dull, aching, throbbing, or pressure-like" (Group II). Patients in Group I tended to have a higher prevalence of a traumatic history (74%) and had the best response, nearly 80%. Overall, Group II patients had a poor response. Follow-up duration was between 19 and 48 months. Other published series for occipital neuralgia were small and without standardized follow-up data.
One retrospective paper evaluated the effects of occipital neurectomy for the treatment of occipital neuralgia of various causes. 80 Other Symptoms. In 1 study investigators evaluated sphenopalatine ganglionectomies for cluster headache 112 and found that patients with an intermittent headache (Group A) had a 60.7% response rate, whereas chronic, continuous headache sufferers (Group B, chronic cluster headache) had only a 30% response. The mean follow-up duration was 29.1 and 24 months, respectively. In 2 small series, one with 4 patients 34 and another with 10, 126 individuals treated with thoracic ganglionectomies for a variety of symptoms were reported. Investigators in both studies claimed some success. Ganglionectomy articles are listed in Table 2 (17 articles).
Studies of DREZ Lesioning
A total of 26 case series was located for DREZ lesioning, the majority of which were published between 1980 and 1989. No Class I or II studies were found. These reports included between 3 and 124 patients with a wide range of follow-up time points. All studies reported a > 50% relief in pain in a majority of patients, and these results tended to be durable. 124 Patients with BPA injuries and traumatic SCIs tended to have the best response to DREZ lesioning in studies that compared different presenting causes directly, whereas patients with postherpetic neuralgia and peripheral neuropathies had the worst response. 41, 98, 106 Outcomes for patients with BPA injuries were quite consistent across series, and ranged from 54 to 86% of patients with > 50% reduction in reported pain levels. 
Studies of Trigeminal Tractotomy for Facial Pain
Eight pertinent articles were found for tractotomy, including the oldest article retrieved for this review. 12 No Class I data were found for this topic. Instead, all papers were case series. The largest case series was reported by Schvarcz in 1975, 116 who found that excellent pain relief was obtained in 16 of 17 patients. Interestingly, all case series reported good to excellent results, even in patients with postherpetic neuralgia. In 1 series, for example, deep pain was eliminated or significantly decreased in all 6 patients with postherpetic craniofacial dysesthesia.
114 Table  4 , with 8 case series, gives an overview of the articles reviewed above. 12, 24, 49, 53, 62, 67, 114, 116 Cordotomy Studies A review of cordotomy studies for patients with nonmalignant pain produced 11 case series, published between 1957 and 1990. No Class I or II studies were found. The number of patients in these case series ranged from 13 to 72, and follow-up duration was between 2 weeks and 10 years. Outcome data from these studies generally demonstrated an overall improvement in patients' reported pain postoperatively compared with preoperative values. Treated patients suffered from a wide variety of nonmalignant pain syndromes ranging from chronic sciatica to incomplete or complete SCI. In 2 case series, 96, 101 cordotomies were performed in patients with common diagnoses: epidural/intradural fibrosis and cauda equina injury. Similar long-term outcomes of 60-65% effectiveness were found in each case.
In general, for studies with long-term follow-up, the benefits from surgery declined with time. However, determining significance was difficult because neither outcome nor follow-up was standardized for these patients. Furthermore, outcome measures were inconsistent between studies, complicating any attempts to make general recommendations. The articles that were included in this review are outlined in Table 5 , which lists 11 case series. 3, 23, 25, 37, 40, 46, 96, 101, 103, 109, 137 
Myelotomy Studies
Three articles examining the use of myelotomy were found. These were small case series (3-14 patients) with variable follow-up periods and pain origins. The largest series 115 reported that 64% of patients experienced a complete or marked reduction in deep "background" pain. Table 6 , with 3 case series, represents a summary of the articles. 10, 115, 127 
Mesencephalotomy Studies
Using the criteria described above, 9 relevant articles were reviewed regarding the use of mesencephalotomy for nonmalignant pain. All of these articles were case series, and most had relatively small numbers of patients. The most recent publication 121 reported the effects of lesions made in 1 of 2 locations in 27 patients with central pain following a stroke. Long-term pain relief was produced in 75% of patients with lesions created at the level of the superior colliculus, although with significant ocular side effects. These side effects were reduced with lesions adjacent to the inferior colliculus. Long-term pain relief was achieved in 58% of patients in this latter group. Follow-up duration was between 3 months and 5 years. In a separate study, 2 good pain relief was produced in 23 patients (67%) with thalamic syndrome and tabes dorsalis who were followed for 3 to 70 months. Table 7 , which lists 9 case series, provides a summary of articles pertaining to mesencephalotomy. 2, 48, 73, 121, 129, 149, 157, 158, 164 
Thalamotomy Studies
All published articles describing thalamotomy were limited to small case series with heterogeneous patient populations. Similar to cingulotomy, the largest case series (85 patients) was not published in a peer-reviewed article, but in book format, 57 and was not included here; however, a subset of patients was described earlier. 58 Follow-up duration, outcome measures, target site, and pain origin were inconsistent within or between series, making definite conclusions difficult. Dougherty et al. 26 and Tasker 136 have provided thorough discussions of thalamotomy. Table 8 , with 12 case series, gives a summary of articles. 3, 20, 50, 58, 65, 71, 84, 86, 107, 120, 149, 162 Cingulotomy Studies A total of 13 original case series focusing on cingulotomy were identified based on our inclusion criteria as described above. Because the largest case series described in the literature (133 patients) was not published as a peerreviewed article, it was not included in our analysis. 4 No Class I or II studies were identified. The largest reviewed case series described 36 patients. Overall, only 2 papers used a validated outcome measure such as the VAS, 155, 159 and only 1 paper had a common diagnosis for their series. 68 Follow-up periods were variable and the majority of the series were published before 1980 (Table 9 and Fig.  1 ). Abdelaziz and Cosgrove 1 provide a detailed description and summary of published case series. Table 9 , with 13 case series, 11, 33, 35, 55, 68, 69, 94, 119, 143, 149, 155, 156, 159 provides a listing of articles pertinent to cingulotomy. Reported case series were small and used variable outcome measures, making comparisons difficult. For most series, authors reported variable outcomes.
Discussion
Despite a history of destructive procedures for the treatment of nonmalignant pain going back to the beginnings of modern neurosurgery, there are relatively few clinical papers in peer-reviewed journals that contain detailed descriptions of long-term outcomes assessed using validated outcome measures and standardized follow-up. The vast majority of published articles constitute case series and uncontrolled chart reviews with a generally heterogeneous population of patients. Inconsistent follow-up, heterogeneous study groups, inconsistent treatment techniques, and lack of either concurrent or historical controls plague the majority of the reviewed studies. Many of these shortcomings simply reflect a change in accepted methods of clinical reporting. Authors of more recent pa- looked at percutaneous rhizotomies or ganglionectomies for the treatment of facet pain or radicular pain, respectively. Overall, these studies showed either a modest treatment effect (in the case of radiofrequency neurotomies for facet pain) consistent with earlier case series, or no effect (in the case of ganglionectomies), despite initial positive results in uncontrolled studies. The foregoing examples highlight the difficulty in extrapolating efficacy results from earlier, uncontrolled studies subject to numerous confounding variables and the value of well-designed controlled studies. Pain studies are especially prone to such confounders as reporting and observer bias, 21 due to the subjective nature of pain and the complete absence of an objective or treatment effect marker. Although the value of validated outcome measures, such as the VAS, as a surrogate for more objective measures is now well recognized, the majority of studies published on destructive procedures for pain do not use the VAS or any other validated outcome measure. Almost all of the reviewed studies showed an early, dramatic response to treatment that tended to decay with long-term follow-up. Such early positive success may represent, at least in part, an expectation by the patient and the physician that the treated pain would improve. In fact, it has been well documented 39 not only that invasive procedures tend to produce a greater placebo effect on patients' symptoms in comparison with noninvasive treatments, but also that these effects decay with time.
The field of pain surgery has suffered from a general pattern of early enthusiasm for new techniques followed by a shift to even newer approaches without adequate establishment of indications and efficacy data for existing procedures. Evidence that adheres to modern standards is limited. The lack of Class I or II studies, however, should not be interpreted as prima facie evidence that ablative techniques are ineffective (Table 10) . Rather, the considerable anecdotal evidence and collective experience of pain surgeons provide a strong foundation on which to base more focused, rigorous studies in which a sound study design is used.
There are many observations reported within the neuroablative literature that are consistent across authors and institutions and warrant further study. Several authors have reported markedly better outcomes when DREZ lesioning was used for the treatment of patients with BPA injuries compared with those with postherpetic neuralgia. 41, 98, 106 Although the effects of confounding variables cannot be ruled out given the uncontrolled nature of the studies, expectation and observer bias at least were probably consistent across groups. The use of DREZ lesioning may provide considerable benefit to patients suffering from denervation pain caused by BPA. This pain syndrome has historically been difficult to treat, including with medications or neuromodulatory techniques, 104, 124 and the efficacy of DREZ lesioning in BPA should be studied in a well-controlled and sufficiently powered study. Similarly, large case series from multiple institutions all show consistent long-term outcomes with similar rates of recurrence for TN treated with rhizotomies. 17, 63, 163 These studies provide strong anecdotal evidence for a significant treatment effect. At present, however, there is still considerable controversy regarding patient selection and the timing of rhizotomies for TN. Many questions remain. Should patients be treated medically as long as possible or should surgery be offered sooner for potential prevention of the development of Type II TN? 16 Should patients be offered microvascular decompression prior to rhizotomies? 95 Important observations have also been made across different treatment modalities and disease origins. Independently, several authors reporting on ablative techniques for the treatment of various causes of pain, ranging from SCI to TN, have observed that pains described as electrical, intermittent, and stabbing 17, 76, 124, 137, 163 were more successfully treated by ablative procedures than those pains described as steady and/or aching. This observation suggests that there may be an underlying difference between these 2 types of pain that may require distinct interventions. These observations regarding BPA, TN, and pain symptomatology are just a few of the examples in the published literature that warrant further study and assessment through focused, well-designed trials. The value of such studies could potentially lead to improvements in patient selection and surgical outcomes as well as to new understandings of the pathophysiological origins of different pain states. How should future studies be designed and conducted if they are to determine accurately and reliably the effectiveness of these surgical procedures in the treatment of pain? In the absence of ethical, financial, and practical considerations, the answer would be simple: double-blinded RCTs in patients with standardized and well-documented diagnoses (Table 11 ). However, RCTs on destructive procedures for nonmalignant pain are difficult to design as well as to implement. First, many of the earlier studies failed to distinguish between different pain states that are now known to have different underlying pathophysiological origins, potentially missing treatable subgroups of patients. The distinction between nociceptive and neuropathic pain states is likely to be particularly crucial, although the limited Class I or II studies available have, to date, focused on nociceptive pain states. Second, a single center rarely has sufficient volume of a particular procedure to power a valid outcome study adequately. Third, the accurate evaluation of surgical pain relief procedures is a difficult task, beyond the usual difficulties that plague most clinical studies, due to the subjective nature of pain and the absence of direct objective measures of its presence, nature, and intensity. There are additional challenges in blinding patients and evaluators to the procedure performed. Although sham surgery has been performed in a neurosurgical clinical trial for the treatment of Parkinson disease, 38 such a practice is highly controversial. 36 More realistically, it should be recognized that useful and meaningful information can be obtained from well-designed studies that incorporate as many of the elements of a Class I study as possible. 21, 22 Modern observational studies using case controls and modern statistics may still demonstrate treatment effects within the confidence intervals of RCTs.
9,22 Important elements include investigator equipoise, blinded or at least impartial evaluators, long follow-up times with intention-to-treat type analyses, validated outcome measures, prospective studies with controls, uniform diagnoses, and uniform surgical techniques. With appropriate and well-designed studies, large numbers of patients may not be needed to begin to answer fundamental questions in the surgical treatment of pain.
Finally, it should be noted that the 146 studies reviewed were limited to peer-reviewed journals by using the criteria outlined in our methodology. Many classic case series and personal observations by pioneers in the field of pain surgery were omitted. As eloquently stated by 2 statesmen in the field "… much information about lesioning surgery in the nervous system for pain relief can be found in textbooks devoted to surgery for pain.…"-J. M. Gybels 
Conclusions
Destructive techniques for the treatment of pain have a long and important history within the field of neurosurgery, but their efficacy has not been well established based on contemporary standards. This comprehensive review of the existing literature on ablative techniques for nonmalignant pain was aimed at summarizing the extent and quality of the evidence supporting these techniques. With very few exceptions, there is limited evidence supporting their efficacy. Modern studies are needed to define appropriate indications and methodologies in the treatment of nonmalignant chronic pain.
